Egypt will export lifesaving insulin injec-tions to Cuba as part of a new pharmaceutical market expansion into Latin America.
The Insulinagypt injections, produced in Egypt and used to treat diabetes, will be exported through the United Company for Pharmaceuticals, an affiliate of the ACDIMA group.
Khaled Abdel Ghaffar, Egypt’s minister of housing, said: “This marks the beginning of a new phase of fruitful cooperation between the Egyptian state and Cuba, with the export of Egyptian-made human insulin.”
He added: “This achievement is significant as it represents the first presence of an Arab-African-Egyptian company supplying Cuba with medicines, namely the United Company for Pharmaceuticals, one of the companies affiliated with the ACDIMA group, led by Dr. Alfat Garab.”
Garab is the chairperson of ACDIMA, which will act as Egyptian representative for the pharmaceutical exports to Cuba.
In a statement, Garab said: “The Arab Company for Drug Industries and Medical Appliances is an Egyptian entity encompassing a collection of leading pharmaceutical manufacturing companies, including the Center for Bioequivalence and Afri Pharma for collaboration with African countries in pharmaceutical products and healthcare services.—AFP
